CPHI Trend Report: The Future of Indian API Manufacturing - Out Now!
Read this new CPHI Trend Report which, via interviews with key industry experts, explores the state of India's API manufacturing issue and how it is being impacted by the country's ambitious healthcare reform programme as well as efforts by the government to support domestic manufacturing and reduce supply dependence on rival China.
India, with a population of almost 1.4 billion, is becoming ever more vocal about access to good quality healthcare and this will have a huge impact on the fortunes of the country’s pharmaceutical sector going forward.
The country’s growing middle-class population in several regions has translated into growing demand and thus bigger healthcare spending, while the estimated 40-50% of the population with still no discernible access to healthcare offers a platform for considerable further growth in the sector, both in preventive and curative terms.
This situation undoubtedly provides fertile ground for manufacturers of both active pharmaceutical products and finished dosage forms.
This report explores the impact of an ambitious healthcare reform programme on India’s API manufacturing and outsourcing sector and examines the extent to which government-funded schemes such as the Production Linked Incentive and the building of API manufacturing parks can be realised.
Click to read Trend Report: The Future of API Manufacturing in India
Related News
-
.png)
News New Aurigene biologics facility opens in Hyderabad, India
Aurigene Pharmaceutical Services Ltd. have opened a biologics facility in Hyderabad, India in a biocluster known as Genome Valley. -
.png)
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
.png)
News CPHI Barcelona Speaker Interview – What the US FDA’s Quality Management Maturity Means for the Pharma Industry
At CPHI Barcelona (24–26 October, 2023), we spoke to Sireesha Yadlapalli, CEO of Pharmatech Associates, who gave a presentation on the implications of the US FDA’s Quality Management Maturity (QMM) Initiative, and spoke on the panel of the ... -
News Women in Pharma: Empowering yourself and other women in pharma
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond.
-
News Novartis agrees for copies to be made of cancer drug to reach poorer countries
Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. -
News Doctors Without Borders demands transparency from GSK on licensing agreements for preventative HIV treatment
GSK has signed licensed agreements with three companies to manufacture generic versions of its preventative HIV medicine for distribution in lower-income countries but calls for increased transparency is putting pressure on the drugmaker. -
News Sai Life Sciences opens new HPAPI manufacturing facility in Bidar, India
A new HPAPI development and manufacturing block is now open at Sai Life Sciences’ Bidar Manufacturing Campus, expanding the CRDMO’s capabilities in small molecule discovery and commercialisation. -
.png)
News CPHI Pharma Award Winners 2022: CEO of the Year – Aragen Life Sciences
In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, in each of the different categories, from digital innovation to CEO of the year.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance